Key Decision and Effective Date

The Board of Directors of Dr. Reddy's Laboratories Limited, at their meeting held on October 23, 2026, approved the appointment of Mr. Akhil Ravi as Head API and Services and Senior Management Personnel of the Company. The appointment is effective from November 13, 2026.

Approval Process

The appointment was made based on the recommendation of both the Nomination, Governance and Compensation Committee and the Audit Committee of the Company.

Additional Roles and Responsibilities

Mr. Akhil Ravi will be inducted as a Member of the Management Council of the Company. He will continue to be responsible for the operations of Aurigene Pharmaceutical Services Ltd., a wholly owned subsidiary of the Company.

Relationship Disclosure

Mr. Akhil Ravi is disclosed as a related party to the Company, being the son-in-law of Mr. G V Prasad, Co-Chairman and Managing Director of Dr. Reddy's Laboratories Limited.

Board Meeting Details

The Board meeting where this appointment was approved commenced at 3:00 p.m. IST and concluded at 4:38 p.m. IST on October 23, 2026.

Professional Background of Mr. Akhil Ravi

Mr. Ravi brings nearly 19 years of experience spanning strategy, commercial leadership, business transformation and general management. He joined Dr. Reddy's Laboratories in 2018 and has held leadership roles across strategy, commercial operations and business leadership. He currently serves as CEO of Aurigene Pharmaceutical Services Ltd. (APSL).

Under his leadership, APSL has evolved from a start-up-style business into a rapidly scaling CRDMO (Contract Research, Development and Manufacturing Organization), driving significant growth, profitability and capability expansion. He has led the transformation of APSL through a multi-year agenda focused on strengthening operating foundations, accelerating growth, improving profitability and enhancing customer service.

Mr. Ravi has been instrumental in advancing APSL's innovation and technology capabilities, including leading the implementation of Aurigene.ai, an AI-enabled integrated drug discovery workflow that supports approximately 30% of the drug discovery services business. He has overseen the expansion of capabilities across drug discovery, antibodies, biologics, APIs and peptides.

Educational Qualifications

  • Post-Graduate Programme in Management from Indian School of Business (ISB)
  • Bachelor of Technology, Chemical Engineering from Indian Institute of Technology (IIT), Bombay

Previous Experience

Before joining Dr. Reddy's, Mr. Ravi held sales and transformation roles at McKinsey & Company and ITC, and pursued entrepreneurial ventures focused on digital sports and health solutions.

Updated Senior Management List

The disclosure includes an updated list of 16 Senior Management Personnel, with Mr. Akhil Ravi now included as Head API and Services at position 15.

#Tags: #DrReddys #ManagementAppointment #Regulation30 #SEBIDisclosure #CorporateGovernance #Neutral